Patrizia Cavazzoni's safety surveillance expertise may come in handy early in her tenure as the Center for Drug Evaluation and Research's deputy director of operations given the US FDA's desire to continue expanding the use of its Sentinel system.
Less than three months into her tenure as the second in command at CDER, Cacazzoni did not list many priorities...
Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?